adpi2 alpha1
Name
agdi2
Label
Alpha-Glucosidase Inhibitors (SHHS2)
Description

Participant taking ALPHA-GLUCOSIDASE INHIBITORS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
AGDI2 diabetes
Alpha-Glucosidase Inhibitors (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total - 4,080 -
No - 3,613 -
Yes - 7 -
Unknown - 460 -
Alpha-Glucosidase Inhibitors (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 176 646 1,146 1,053 552 40 3,613
Yes - 1 2 3 1 - 7
Unknown 8 60 173 144 71 4 460
Alpha-Glucosidase Inhibitors (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,657 1,956 3,613
Yes 4 3 7
Unknown 200 260 460
Alpha-Glucosidase Inhibitors (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,155 242 216 3,613
Yes 7 - - 7
Unknown 425 14 21 460